These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34595561)

  • 1. Monitoring process-related impurities in biologics-host cell protein analysis.
    Pilely K; Johansen MR; Lund RR; Kofoed T; Jørgensen TK; Skriver L; Mørtz E
    Anal Bioanal Chem; 2022 Jan; 414(2):747-758. PubMed ID: 34595561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA.
    Gunawan F; Nishihara J; Liu P; Sandoval W; Vanderlaan M; Zhang H; Krawitz D
    Biotechnol Bioeng; 2018 Feb; 115(2):382-389. PubMed ID: 28986978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.
    Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR
    Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated strategy for deep profiling of host cell proteins in downstream processing of therapeutic monoclonal antibodies: Novel approach to isolate and digest host cell proteins.
    Zarei M; Jonveaux J; Razvi A; Jahn M
    Eur J Pharm Biopharm; 2024 Aug; 201():114369. PubMed ID: 38885909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of host cell proteins (HCPs) in a mammalian cell-derived antibody drug using liquid chromatography/mass spectrometry in conjunction with an HCP-enrichment strategy.
    Thompson JH; Chung WK; Zhu M; Tie L; Lu Y; Aboulaich N; Strouse R; Mo WD
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):855-60. PubMed ID: 24623688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.
    Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J
    MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
    Huang Y; Molden R; Hu M; Qiu H; Li N
    J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development.
    Guo J; Kufer R; Li D; Wohlrab S; Greenwood-Goodwin M; Yang F
    MAbs; 2023; 15(1):2213365. PubMed ID: 37218066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward optimal clearance: A universal affinity-based mass spectrometry approach for comprehensive ELISA reagent coverage evaluation and HCP hitchhiker analysis.
    Seisenberger C; Graf T; Haindl M; Wegele H; Wiedmann M; Wohlrab S
    Biotechnol Prog; 2022 May; 38(3):e3244. PubMed ID: 35150475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SWATH-MS as a strategy for CHO host cell protein identification and quantification supporting the characterization of mAb purification platforms.
    Carvalho SB; Profit L; Krishnan S; Gomes RA; Alexandre BM; Clavier S; Hoffman M; Brower K; Gomes-Alves P
    J Biotechnol; 2024 Mar; 384():1-11. PubMed ID: 38340900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products.
    Falkenberg H; Waldera-Lupa DM; Vanderlaan M; Schwab T; Krapfenbauer K; Studts JM; Flad T; Waerner T
    Biotechnol Prog; 2019 May; 35(3):e2788. PubMed ID: 30767403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.
    Hogwood CE; Bracewell DG; Smales CM
    Bioengineered; 2013; 4(5):288-91. PubMed ID: 23328085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-house CHO HCPs platform: A promising approach for HCPs ELISA monitoring.
    Giordano E; Liori B; Cecchini I; Verani R; Leone L
    Eur J Pharm Sci; 2024 Jan; 192():106656. PubMed ID: 38029932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell protein testing by ELISAs and the use of orthogonal methods.
    Zhu-Shimoni J; Yu C; Nishihara J; Wong RM; Gunawan F; Lin M; Krawitz D; Liu P; Sandoval W; Vanderlaan M
    Biotechnol Bioeng; 2014 Dec; 111(12):2367-79. PubMed ID: 24995961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner.
    Chen IH; Xiao H; Li N
    Anal Biochem; 2020 Dec; 610():113972. PubMed ID: 32979367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).
    Farrell A; Mittermayr S; Morrissey B; Mc Loughlin N; Navas Iglesias N; Marison IW; Bones J
    Anal Chem; 2015 Sep; 87(18):9186-93. PubMed ID: 26280711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry.
    Doneanu CE; Xenopoulos A; Fadgen K; Murphy J; Skilton SJ; Prentice H; Stapels M; Chen W
    MAbs; 2012; 4(1):24-44. PubMed ID: 22327428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination.
    Waldera-Lupa DM; Jasper Y; Köhne P; Schwichtenhövel R; Falkenberg H; Flad T; Happersberger P; Reisinger B; Dehghani A; Moussa R; Waerner T
    MAbs; 2021; 13(1):1955432. PubMed ID: 34347561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a host cell protein impurity in therapeutic protein, P1.
    Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
    J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.